PRESENTATION ON DENGUE.pptx

download PRESENTATION ON DENGUE.pptx

of 29

Transcript of PRESENTATION ON DENGUE.pptx

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    1/29

    A CROSS SECTIONAL STUDY TO KNOW THE

    RELATIONSHIP BETWEEN SEVERITY OF

    THROMBOCYTOPENIA AND SEVERITY OFDENGUE IN PEDIATRIC WARD OF GGH,

    KURNOOL

    By:K. JagannathSingh.

    Teacher

    Indus High SchoolKurnool

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    2/29

    Dengue fever is a major public health problem intropical and subtropical countries

    The reasons for the emergence of this disease arecomplex

    Effective mosquito control is virtuallynonexistent in most dengue-endemic countries

    Major global demographic changes have occurred

    Uncontrolled urbanizationConcurrent population growth

    Substandard housing, inadequate water,

    sewer, and waste management systems

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    3/29

    To reveal the prevalence of Dengue amongsuspected case of dengue(VHF)

    Understand the relationship betweenseverity of thrombocytopenia versusseverity of Dengue

    To study whether the platelet count bearsany relation with new WHO classificationof Dengue(2009)

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    4/29

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    5/29

    Dengue is cause by a RNA virusThis virus is a member of the viral familyFlaviviridae.

    Dengue virus

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    6/29

    Aedes aegypti Aedes albopictus

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    7/29

    2-7 days

    >4 days

    2days

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    8/29

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    9/29

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    10/29

    Dengue is one disease entity withdifferent clinical presentationsandoften withunpredictableclinicalevolutionandoutcome

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    11/29

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    12/29

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    13/29

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    14/29

    Study settings: Pediatric ward of KMC/GGH Kurnool

    Study design :Cross-sectional study

    Study subjects:70 Sampling method: All suspected cases of

    Dengue admitted in pediatric ward

    Study period: Schedule 1.06.2011to19.09.2011

    Data collected was analyzed in MS

    excel

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    15/29

    Mean age: 4 years Mode for age:3 Median for age:7 years

    Range:7 months to 14 years

    Mean platelet count:33,214 Mode:40,000 Median:47,000 Range:2000 to 1,00,000

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    16/29

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    17/29

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    18/29

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    19/29

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    20/29

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    21/29

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    22/29

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    23/29

    Platelets Severe Dengue (+ve) Severe Dengue (-ve)Total

    20,000 10 6 16

    > 20,000 14 40 54

    Total 24 46 70

    Chi square value > 7.29P value < 0.01 (highly significant)df=1

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    24/29

    In my study 43 were +Ve for dengueamong them 24 were diagnosed as severDengue out of 70 cases of Dengue

    In K. Oishi and all in,Nagasakiuniversity,Japan. 38 were +Ve for severdengue among 78 cases of secondary

    dengue

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    25/29

    The prevalence rate of Dengue is (43/70 100) Age wise distribution of Dengue cases Gender distribution of dengue Distribution of cases according to WHO

    classification of Dengue Relation among platelet counts and different forms

    of Dengue Case fatality rate (3/70 100)

    The strength of association between severity ofDengue and severity of thrombocytopenia wasfound to be statistically significant with a P value

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    26/29

    Special thanks to my beloved Professors:Dr. P.Sudhakar Rao MD Gen Med

    Dr. A.Sreedevi Prof & HOD of SPM

    Assistant professor:Dr.S.Cynthia SubhapradaMy colleagues:

    Bala Kumar.D

    Divya.B

    Bhupathi Naidu.K

  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    27/29

    WHO Library Cataloguing-in-Publication Data

    Dengue: guidelines for diagnosis, treatment, prevention and control -- New

    edition.

    1.Dengue - diagnosis. 2.Dengue - therapy. 3.Dengue - prevention and control.

    4.Endemic Diseases -

    prevention and control. 5.Fluid therapy. 6.Diagnosis, differential. 7.Disease

    outbreaks - prevention and

    control. 8.Mosquito control. 9.Guidelines. I.World Health Organization.

    ISBN 978 92 4 1 Mayo clinic, (2010). Dengue fever symptoms. Retrieved April 19, 2010 from

    http://www.mayoclinic.com/health/dengue_fever/DS01028/DSECTION=symptoms

    54787 1 (NLM classification: WC 528) World Health Organization, (2009). Dengue and Dengue haemorrhagic fever.

    Retrieved April 19, 2010 from

    http://www.who.int/mediacentre/factsheets/fs117/en

    http://www.mayoclinic.com/health/dengue_fever/DS01028/DSECTION=symptomshttp://www.who.int/mediacentre/factsheets/fs117/en/http://www.who.int/mediacentre/factsheets/fs117/en/http://www.mayoclinic.com/health/dengue_fever/DS01028/DSECTION=symptoms
  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    28/29

    :

    Dengue Fever , disease information:http://www.cdc.gov/ncidod/Diseases/submen

    us/sub_dengue.htm

    CDC-Dengue:http://www.cdc.gov/ncidod/dvbid/dengue/

    WHO/Dengue/dengue haemorrhagic fever:http://www.who.int/csr/disease/dengue/en/

    http://www.cdc.gov/ncidod/Diseases/sudmenus/sub_dengue.htmhttp://www.cdc.gov/ncidod/Diseases/sudmenus/sub_dengue.htmhttp://www.cdc.gov/ncidod/dvbid/dengue/http://www.cdc.gov/ncidod/dvbid/dengue/http://www.cdc.gov/ncidod/Diseases/sudmenus/sub_dengue.htmhttp://www.cdc.gov/ncidod/Diseases/sudmenus/sub_dengue.htm
  • 7/30/2019 PRESENTATION ON DENGUE.pptx

    29/29

    Thank you